These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 10212133

  • 1. 5-Aryl-1,2,3,4-tetrahydrochromeno[3,4-f]quinolin-3-ones as a novel class of nonsteroidal progesterone receptor agonists: effect of A-ring modification.
    Zhi L, Tegley CM, Marschke KB, Mais DE, Jones TK.
    J Med Chem; 1999 Apr 22; 42(8):1466-72. PubMed ID: 10212133
    [Abstract] [Full Text] [Related]

  • 2. 5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal human progesterone receptor agonists.
    Zhi L, Tegley CM, Kallel EA, Marschke KB, Mais DE, Gottardis MM, Jones TK.
    J Med Chem; 1998 Jan 29; 41(3):291-302. PubMed ID: 9464360
    [Abstract] [Full Text] [Related]

  • 3. 5-Benzylidene 1,2-dihydrochromeno[3,4-f]quinolines, a novel class of nonsteroidal human progesterone receptor agonists.
    Tegley CM, Zhi L, Marschke KB, Gottardis MM, Yang Q, Jones TK.
    J Med Chem; 1998 Oct 22; 41(22):4354-9. PubMed ID: 9784110
    [Abstract] [Full Text] [Related]

  • 4. Characterization of a new class of selective nonsteroidal progesterone receptor agonists.
    Dong Y, Roberge JY, Wang Z, Wang X, Tamasi J, Dell V, Golla R, Corte JR, Liu Y, Fang T, Anthony MN, Schnur DM, Agler ML, Dickson JK, Lawrence RM, Prack MM, Seethala R, Feyen JH.
    Steroids; 2004 Mar 22; 69(3):201-17. PubMed ID: 15072922
    [Abstract] [Full Text] [Related]

  • 5. 5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists: the effect of D-ring substituents.
    Edwards JP, West SJ, Marschke KB, Mais DE, Gottardis MM, Jones TK.
    J Med Chem; 1998 Jan 29; 41(3):303-10. PubMed ID: 9464361
    [Abstract] [Full Text] [Related]

  • 6. Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones.
    Higuchi RI, Arienti KL, López FJ, Mani NS, Mais DE, Caferro TR, Long YO, Jones TK, Edwards JP, Zhi L, Schrader WT, Negro-Vilar A, Marschke KB.
    J Med Chem; 2007 May 17; 50(10):2486-96. PubMed ID: 17439112
    [Abstract] [Full Text] [Related]

  • 7. Discovery and preliminary SAR studies of a novel, nonsteroidal progesterone receptor antagonist pharmacophore.
    Pooley CL, Edwards JP, Goldman ME, Wang MW, Marschke KB, Crombie DL, Jones TK.
    J Med Chem; 1998 Aug 27; 41(18):3461-6. PubMed ID: 9719599
    [Abstract] [Full Text] [Related]

  • 8. Nonsteroidal human progesterone receptor modulators from the marine alga Cymopolia barbata.
    Pathirana C, Stein RB, Berger TS, Fenical W, Ianiro T, Mais DE, Torres A, Goldman ME.
    Mol Pharmacol; 1995 Mar 27; 47(3):630-5. PubMed ID: 7700260
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget.
    Fensome A, Bender R, Chopra R, Cohen J, Collins MA, Hudak V, Malakian K, Lockhead S, Olland A, Svenson K, Terefenko EA, Unwalla RJ, Wilhelm JM, Wolfrom S, Zhu Y, Zhang Z, Zhang P, Winneker RC, Wrobel J.
    J Med Chem; 2005 Aug 11; 48(16):5092-5. PubMed ID: 16078826
    [Abstract] [Full Text] [Related]

  • 10. 1,5-Dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5'-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulators.
    Kern JC, Terefenko EA, Fensome A, Unwalla R, Wrobel J, Cohen J, Zhu Y, Berrodin TJ, Yudt MR, Winneker RC, Zhang Z, Zhang P.
    Bioorg Med Chem Lett; 2008 Sep 15; 18(18):5015-7. PubMed ID: 18722119
    [Abstract] [Full Text] [Related]

  • 11. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
    Vacher B, Bonnaud B, Funes P, Jubault N, Koek W, Assié MB, Cosi C, Kleven M.
    J Med Chem; 1999 May 06; 42(9):1648-60. PubMed ID: 10229633
    [Abstract] [Full Text] [Related]

  • 12. Nonsteroidal progesterone receptor ligands (I): synthesis and SAR of new tetrahydronaphthofuranone derivatives.
    Shinei R, Kurihara K, Tanabe K, Tabata Y, Kurata Y, Hoshiko S, Okonogi T.
    Bioorg Med Chem; 2006 Jul 15; 14(14):4850-61. PubMed ID: 16580213
    [Abstract] [Full Text] [Related]

  • 13. 5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulators.
    Zhi L, Tegley CM, Pio B, Edwards JP, Motamedi M, Jones TK, Marschke KB, Mais DE, Risek B, Schrader WT.
    J Med Chem; 2003 Sep 11; 46(19):4104-12. PubMed ID: 12954062
    [Abstract] [Full Text] [Related]

  • 14. Preparation, resolution, and biological evaluation of 5-aryl-1, 2-dihydro-5H-chromeno[3,4-f]quinolines: potent, orally active, nonsteroidal progesterone receptor agonists.
    Edwards JP, Zhi L, Pooley CL, Tegley CM, West SJ, Wang MW, Gottardis MM, Pathirana C, Schrader WT, Jones TK.
    J Med Chem; 1998 Jul 16; 41(15):2779-85. PubMed ID: 9667968
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonists based on cyclocymopol monomethyl ether.
    Hamann LG, Farmer LJ, Johnson MG, Bender SL, Mais DE, Wang MW, Crombie D, Goldman ME, Jones TK.
    J Med Chem; 1996 Apr 26; 39(9):1778-89. PubMed ID: 8627601
    [Abstract] [Full Text] [Related]

  • 16. 5-Aryl indanones and derivatives as non-steroidal progesterone receptor modulators.
    Kern JC, Terefenko E, Trybulski E, Berrodin TJ, Cohen J, Winneker RC, Yudt MR, Zhang Z, Zhu Y, Zhang P.
    Bioorg Med Chem Lett; 2009 Dec 01; 19(23):6666-9. PubMed ID: 19864132
    [Abstract] [Full Text] [Related]

  • 17. Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling.
    Frølund B, Jensen LS, Guandalini L, Canillo C, Vestergaard HT, Kristiansen U, Nielsen B, Stensbøl TB, Madsen C, Krogsgaard-Larsen P, Liljefors T.
    J Med Chem; 2005 Jan 27; 48(2):427-39. PubMed ID: 15658856
    [Abstract] [Full Text] [Related]

  • 18. Detection of potential (anti)progestagenic endocrine disruptors using a recombinant human progesterone receptor binding and transactivation assay.
    Viswanath G, Halder S, Divya G, Majumder CB, Roy P.
    Mol Cell Endocrinol; 2008 Nov 25; 295(1-2):1-9. PubMed ID: 18801410
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis and SAR studies of 2-oxoquinoline derivatives as CB2 receptor inverse agonists.
    Raitio KH, Savinainen JR, Vepsäläinen J, Laitinen JT, Poso A, Järvinen T, Nevalainen T.
    J Med Chem; 2006 Mar 23; 49(6):2022-7. PubMed ID: 16539390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.